Product Description
Naproxen
Usage Statement
Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
Key Applications
Inhbitor
Specifications
| SKU | 02190247-CF |
| Alternate Names | S(+)-6-methoxy-α-methyl-2-naphthaleneacetic acid); [S(+)-2-(6-Methoxy-2-naphthyl)propionic acid] |
| Base Catalog Number | 190247 |
| Beilstein Registry Number | 3591068 |
| Biochemical Physiological Actions | Non-selective cyclooxygenase (COX-1 and COX-2) inhibitor. Naproxen has been demonstrated to block Aβ fibril growth and form a complex with copper (II). |
| CAS # | 22204-53-1 |
| EC Number | 244-838-7 |
| Format | Powder |
| Hazard Statements | H301 |
| Melting Point | 152–155 °C |
| Molecular Formula | C14H14O3 |
| Molecular Weight | 230.263 g/mol |
| Optical Rotation | +59° to +62° |
| Preparation Method | P301 + P310 |
| RTECS Number | UF5275000 |
| Solubility | Soluble in water (>3 mg/mL) at 25 °C; PBS pH 7.2; SOL.; ethanol; DMSO; DMF (100 mg/mL); chloroform; dichloromethane; ether; ethyl acetate; methanol; and THF. Soluble in acetone (50 mg/mL). |
| Storage | Room Temperature |
| Usage Statement | Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department. |
| Vapor Pressure | 1.89X10-6 mm Hg at 25 deg C (est) |
Documents
Certificate of Analysis (COA)
Safety Data Sheets
English (United States)